# Tagworks Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tagworks-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Arnhem, Netherlands
- Website: www.tagworkspharma.com
- Total disclosed funding: $65M
- Latest round: Series A (Jun 22, 2023)
- Investors on record: 7

## About

Founded in 2011 and based in the Netherlands, Tagworks Pharmaceuticals BV operates as a developer of antibody-drug-conjugates and therapeutic technology intended to boost the effectiveness of cancer treatments. In June 2023, Tagworks Pharmaceuticals BV raised USD 65 million in series A funding co-led by Gilde Healthcare Partners, and Ysios Capital Partners with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures. As of 2023, the company is led by its CEO, Marc Robillard.

Tagworks Pharma provides comprehensive packaging solutions that ensure product safety, regulatory compliance, and efficient supply chain management. The company’s product pipeline includes TGW101, an antibody-drug conjugate (ADC) targeting TAG72, a clinically-validated, pan-carcinoma target that so far has remained out of reach of current ADC therapies.

The company plans to use the June 2023 funding to broaden the pipeline and progress click-cleavable ADC targeting TAG72, into clinical trials.

## Funding rounds

- Series A, Jun 22, 2023, $65M — New Enterprise Associates, Novartis Venture Fund, Gilde Healthcare, Ysios Capital Partners, Oost NL, Lightstone Ventures, Meneldor

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series A
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series A
- Oost NL (https://capitalatlas.ai/funds/oost-nl) — Series A
- Lightstone Ventures (https://capitalatlas.ai/funds/lightstone-ventures) — Series A
- Meneldor (https://capitalatlas.ai/funds/meneldor) — Series A